HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 43 filers reported holding HEPION PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $149,026 | +224.5% | 191,754 | +25.3% | 0.00% | – |
| Q4 2022 | $45,918 | -61.1% | 153,029 | -33.7% | 0.00% | – |
| Q3 2022 | $118,000 | +3.5% | 230,690 | +16.8% | 0.00% | – |
| Q2 2022 | $114,000 | -68.4% | 197,569 | -29.5% | 0.00% | – |
| Q1 2022 | $361,000 | -40.0% | 280,099 | -46.9% | 0.00% | – |
| Q4 2021 | $602,000 | -47.7% | 527,714 | -29.9% | 0.00% | – |
| Q3 2021 | $1,152,000 | -33.3% | 753,152 | -13.7% | 0.00% | – |
| Q2 2021 | $1,728,000 | -25.5% | 872,566 | -30.8% | 0.00% | – |
| Q1 2021 | $2,320,000 | +90.2% | 1,260,661 | +126.3% | 0.00% | – |
| Q4 2020 | $1,220,000 | +2159.3% | 557,064 | +3083.2% | 0.00% | – |
| Q3 2020 | $54,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 923,230 | $2,022,000 | 0.82% |
| Worth Venture Partners, LLC | 233,947 | $512,000 | 0.40% |
| PERKINS CAPITAL MANAGEMENT INC | 150,000 | $329,000 | 0.22% |
| GSA CAPITAL PARTNERS LLP | 89,067 | $195,000 | 0.03% |
| PREMIER ASSET MANAGEMENT LLC | 70,000 | $153,000 | 0.03% |
| Allen Capital Group, LLC | 23,685 | $52,000 | 0.01% |
| ZEKE CAPITAL ADVISORS, LLC | 50,000 | $110,000 | 0.01% |
| Prospera Financial Services Inc | 39,300 | $86,000 | 0.01% |
| Onex Canada Asset Management Inc. | 20,000 | $44,000 | 0.00% |
| Schonfeld Strategic Advisors LLC | 95,300 | $208,000 | 0.00% |